Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Nicotine from cigarette smoking and diet and Parkinson disease: a review.

Ma C, Liu Y, Neumann S, Gao X.

Transl Neurodegener. 2017 Jul 2;6:18. doi: 10.1186/s40035-017-0090-8. eCollection 2017. Review.

2.

Association of Serum Uric Acid Level with the Severity of Brain Injury and Patient's Outcome in Severe Traumatic Brain Injury.

Hatefi M, Dastjerdi MM, Ghiasi B, Rahmani A.

J Clin Diagn Res. 2016 Dec;10(12):OC20-OC24. doi: 10.7860/JCDR/2016/21918.8993. Epub 2016 Dec 1.

3.

Micronutrients and Risk of Parkinson's Disease: A Systematic Review.

Sherzai AZ, Tagliati M, Park K, Pezeshkian S, Sherzai D.

Gerontol Geriatr Med. 2016 Apr 22;2:2333721416644286. doi: 10.1177/2333721416644286. eCollection 2016 Jan-Dec.

4.

Urate as a Marker of Risk and Progression of Neurodegenerative Disease.

Paganoni S, Schwarzschild MA.

Neurotherapeutics. 2017 Jan;14(1):148-153. doi: 10.1007/s13311-016-0497-4. Review.

PMID:
27995438
5.

Intake of antioxidant vitamins and risk of Parkinson's disease.

Hughes KC, Gao X, Kim IY, Rimm EB, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A.

Mov Disord. 2016 Dec;31(12):1909-1914. doi: 10.1002/mds.26819. Epub 2016 Oct 27.

PMID:
27787934
6.

Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.

Sarkar S, Raymick J, Imam S.

Int J Mol Sci. 2016 Jun 8;17(6). pii: E904. doi: 10.3390/ijms17060904. Review.

7.

Purines: forgotten mediators in traumatic brain injury.

Jackson EK, Boison D, Schwarzschild MA, Kochanek PM.

J Neurochem. 2016 Apr;137(2):142-53. doi: 10.1111/jnc.13551. Epub 2016 Feb 25. Review.

8.

Prospective study of plasma urate and risk of Parkinson disease in men and women.

Gao X, O'Reilly ÉJ, Schwarzschild MA, Ascherio A.

Neurology. 2016 Feb 9;86(6):520-6. doi: 10.1212/WNL.0000000000002351. Epub 2016 Jan 13.

9.

Midlife milk consumption and substantia nigra neuron density at death.

Abbott RD, Ross GW, Petrovitch H, Masaki KH, Launer LJ, Nelson JS, White LR, Tanner CM.

Neurology. 2016 Feb 9;86(6):512-9. doi: 10.1212/WNL.0000000000002254. Epub 2015 Dec 9.

10.

Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis.

Oh SI, Baek S, Park JS, Piao L, Oh KW, Kim SH.

J Clin Neurol. 2015 Oct;11(4):376-82. doi: 10.3988/jcn.2015.11.4.376.

11.

Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.

Pakpoor J, Seminog OO, Ramagopalan SV, Goldacre MJ.

BMC Neurol. 2015 Feb 28;15:16. doi: 10.1186/s12883-015-0273-9.

12.

Mendelian randomization of serum urate and parkinson disease progression.

Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A; Parkinson Study Group.

Ann Neurol. 2014 Dec;76(6):862-8. doi: 10.1002/ana.24281. Epub 2014 Oct 3.

13.

Total fructose intake and risk of hypertension: a systematic review and meta-analysis of prospective cohorts.

Jayalath VH, Sievenpiper JL, de Souza RJ, Ha V, Mirrahimi A, Santaren ID, Blanco Mejia S, Di Buono M, Jenkins AL, Leiter LA, Wolever TM, Beyene J, Kendall CW, Jenkins DJ.

J Am Coll Nutr. 2014;33(4):328-39. doi: 10.1080/07315724.2014.916237. Epub 2014 Aug 21. Review.

14.

Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis.

Chen X, Guo X, Huang R, Chen Y, Zheng Z, Shang H.

PLoS One. 2014 Apr 8;9(4):e94084. doi: 10.1371/journal.pone.0094084. eCollection 2014.

15.

The emerging role of nutrition in Parkinson's disease.

Seidl SE, Santiago JA, Bilyk H, Potashkin JA.

Front Aging Neurosci. 2014 Mar 7;6:36. doi: 10.3389/fnagi.2014.00036. eCollection 2014. Review.

16.

Emerging candidate biomarkers for Parkinson's disease: a review.

Saracchi E, Fermi S, Brighina L.

Aging Dis. 2013 Oct 9;5(1):27-34. doi: 10.14366/AD.2014.050027. eCollection 2014 Feb. Review.

17.

Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.

AlDakheel A, Kalia LV, Lang AE.

Neurotherapeutics. 2014 Jan;11(1):6-23. doi: 10.1007/s13311-013-0218-1. Review.

18.

Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.

Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I; Huntington Study Group PHAROS Investigators.

JAMA Neurol. 2013 Nov;70(11):1382-8. doi: 10.1001/jamaneurol.2013.3487.

19.

Alcohol Consumption, Types of Alcohol, and Parkinson's Disease.

Liu R, Guo X, Park Y, Wang J, Huang X, Hollenbeck A, Blair A, Chen H.

PLoS One. 2013 Jun 19;8(6):e66452. doi: 10.1371/journal.pone.0066452. Print 2013.

20.

Acetaldehyde and parkinsonism: role of CYP450 2E1.

Vaglini F, Viaggi C, Piro V, Pardini C, Gerace C, Scarselli M, Corsini GU.

Front Behav Neurosci. 2013 Jun 21;7:71. doi: 10.3389/fnbeh.2013.00071. eCollection 2013.

Supplemental Content

Support Center